Compulsory HPV vaccination [14]

New England Journal of Medicine

Volumn 356, Issue 10, 2007, Pages 1074-1075

  Basu, Sanjay ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18; PAPILLOMA VIRUS VACCINE; UNCLASSIFIED DRUG;

HEALTH CARE POLICY; HUMAN; IMMUNOGENETICS; LETTER; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS; FEMALE; LEGAL ASPECT; MANDATORY PROGRAM; MASS IMMUNIZATION; NOTE; TREATMENT REFUSAL; UNITED STATES; UTERINE CERVIX TUMOR; DISEASE TRANSMISSION; HERD IMMUNITY; IMMUNOLOGY; MALE; WOMEN'S HEALTH;

FEMALE; HUMANS; MANDATORY PROGRAMS; MASS IMMUNIZATION; MICHIGAN; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; TREATMENT REFUSAL; UNITED STATES; UTERINE CERVICAL NEOPLASMS; IMMUNITY, HERD; MALE; WOMEN'S HEALTH;

EID: 33847725846     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc063713     Document Type: Letter

References (2)

1. Colgrove J. The ethics and politics of compulsory HPV vaccination. N Engl J Med 2006;355:2389-91.
2. Block SL, Nolan T, Sattler C, et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006;118:2135-45.